The eLitMed.hu medical portal uses computer cookies for convenient operation. Detailed information can be found in the Cookie-policy.

Content

Archives

Thrombosis management

APRIL 27, 2020

[Rivaroxaban’s impact on renal decline in patients with nonvalvular atrial fibrillation: A US MarketScan Claims Database Analysis]

[ ]

PDF| Summary COPYRIGHT FEES
HUN

Thrombosis management

APRIL 27, 2020

[Effectiveness and safety of rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and coronary or peripheral artery disease]

CRAIG I. Coleman, WILLIAM L. Baker, ANNA-KATHARINA Meinecke, ERIKSSON Daniel, BRANDON K. Martinez, THOMAS J. Bunz, ALBERTS J. Mark

[ ]

PDF| Summary COPYRIGHT FEES
HUN

Thrombosis management

APRIL 27, 2020

[Comparative effectiveness of rivaroxaban versus a vitamin K antagonist in patients with renal impairment treated for non-valvular atrial fibrillation in Germany - A retrospective cohort study]

HENDRIK Bonnemeier, HUELSEBECK Maria, SEBASTIAN Kloss

[ ]

PDF| Summary COPYRIGHT FEES
HUN

Thrombosis management

APRIL 27, 2020

[Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation]

CRAIG I. Coleman, JEAN-BAPTISTE Briere, LAURENT Fauchier, PIERRE Levy, BOWRIN Kevin, MONDHER Toumi, AURÉLIE Millier, VANESSA Taieb, WU Olivia

[ ]

PDF| Summary COPYRIGHT FEES
HUN